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SUMMARY
Peripheral arterial disease (PAD) is stenosis or occlusion of
peripheral arterial vessels by atherosclerotic plaque.  It may
present as intermittent claudication, rest pain and
impotence.  PAD of the lower limbs is the third most
important site of atherosclerotic disease after coronary heart
disease and cerebrovascular disease. Increasing age, family
history, smoking, hypertension, dyslipidemia and more
decisively diabetes are significant risk factors.  PAD is a
clinical condition that has often been neglected,
underdiagnosed, undertreated and has a serious outcome. It
may lead to nonhealing wounds, gangrene and amputation
of the lower limbs.  Hence, early identification of patients at
risk of PAD and timely referral to the vascular surgeon in
severe cases is crucial.
KEY WORDS:
Peripheral arterial disease, Intermittent claudication,
Atherosclerotic plaque, Ischaemia, cerebrovascular disease
INTRODUCTION
Peripheral arterial disease (PAD) is stenosis or occlusion of
peripheral arterial vessels by atherosclerotic plaque, which
results in inadequate muscle perfusion and ischaemia1.  It
may present as intermittent claudication, rest pain and
impotence2.  It is one of a triad of vascular diseases caused by
arteriosclerosis, the leading cause of death and disability in
persons aged 50 years and above3.  PAD of the lower limbs is
the third most important site of atherosclerotic disease after
coronary heart disease and cerebrovascular disease2.  PAD is a
clinical condition that has often been neglected,
underdiagnosed, undertreated and has serious outcome3.
Early identification of patients at risk of PAD, evaluating the
disease progression with the use of appropriate tests,
managing its complications and timely referral to the vascular
surgeon in severe cases are important.
This review was prepared by searching the Proquest, Ovid full
text and Medline with keywords PAD, PAD AND diabetes,
PAD AND diagnosis AND management from year 1970-2004.
Prevalence
The prevalence of PAD in the general population varies from
2% to 18% between the ages of 40 and 80 years2.  In diabetic
populations, the prevalence is higher and ranges from 10-
42%4- 6.
Risk Factors 
Epidemiological data among the general population have
shown that male gender, ageing, family history, smoking,
diabetes mellitus, hypertension and dyslipidemia are
significant risk factors for PAD,2 and diabetes mellitus is a
particularly important risk factor. PAD is commoner in males,
especially atherosclerosis of the lower extremities in the
elderly males,2 but  in diabetics, females have a similar
prevalence5.
Hypertension is the most prevalent risk factor for
atherosclerosis1.   The Framingham data have documented a
2.5 fold increase in the risk of PAD in men with hypertension
and 3.9 fold increase of the risk in women7.
PAD is more common among diabetics, and type 2 diabetics
are 20 times more likely to develop PAD than non diabetics8.
This is because PAD progresses more rapidly in diabetics and
its disease pattern is more diffuse9.  Diabetic patients are at
greater risk of developing peripheral macroangiopathy and
microangiopathy10.  However, the detection of PAD in
diabetics may be masked by the presence of peripheral
neuropathy (PN) and calcification of medial arteries. In
diabetic patients with PAD and PN, ischaemic symptoms are
usually not felt due to reduced sensation and the ankle
systolic pressure is not reduced while measuring ankle
brachial pressure index (ABPI) due to calcification of medial
arteries11.  The American Diabetic Association has estimated
that 40% to 50% of all DM related amputations are
preventable8.   Therefore early detection of PAD in the
diabetic population is extremely important.
Dyslipidemia has been associated with an increased
prevalence of PAD.  Although some studies have documented
total cholesterol concentration as an independent risk
factor,12 others have suggested that the ratio of high density
to total cholesterol is perhaps a better predictor13.  Hereditary
disorders such as hypobetalipoproteinemia, type III
hyperlipoproteinemia and lifestyle factors such as high fat
diet and physical inactivity increase the severity of vascular
disease1.
Smoking is a major risk factor for atherosclerosis1. The risk of
PAD was documented to be twice in smokers as compared to
non-smokers in the Framingham study7.  The increased risk
seems to correlate with the number of cigarettes smoked, and
cessation of smoking has been associated with a rapid
decrease in the risk of intermittent claudication7.  Smokers
have an increased rate of PAD progression, higher amputation
rates and lower success rates following vascular
intervention14.
Staging of Pad
Leriche and Fontaine have classified PAD into four stages2.   In
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stage 1, patients are usually asymptomatic, and at this stage
history may reveal paresthesia and cold extremities and
objective examination will show normal, diminished or
absent pulses or an ankle brachial pressure index (ABPI) of
less than 0.9.   In stage two patients may exhibit symptoms of
intermittent claudication (IC).  This stage may be further
subdivided into Stage 2A and 2B.  In stage 2A pain occurs
when the walking distance (WD) is greater than 200m and in
stage 2B pain occurs even if the WD is less than 200m.  Stage
3 is characterized by rest pain (critical ischaemia), which
usually gives trouble at night.  In stage 4, ulceration ranging
from trophic lesions to gangrene are apparent.   Stages 3 and
4 of PAD have been defined as chronic critical leg ischaemia2.
Symptoms of Pad
Most patients with PAD have no symptoms until late in the
disease, as the disease is not clinically evident until
approximately 70% of the vessel’s lumen is occluded1.
Symptomatic PAD ranges in severity from IC to critical limb
ischaemia. Intermittent claudication presents with a
characteristic history of pain in the muscle, typically in the
calf, thigh or buttock, which is elicited by exertion and
relieved within a few minutes of rest.  The level and extent of
PAD determines the location of the pain and also the amount
of exercise needed to produce it.  The distal lesions in the
femoral, popliteal, or tibial arteries produces a cramping pain
in the calf muscles, while proximal or aortoiliac occlusive
lesions usually bring on an aching discomfort, often
associated with a sensation of weakness in the hip, buttocks
or thigh15.  Thus the patient’s level of activity will influence
the symptoms of IC. Patients who are active commonly
experience functional limitation earlier than those who are
sedentary16.
On the other hand, critical limb ischaemia is manifested by
pain at rest, nonhealing wounds and gangrene. Ischaemic rest
pain is typically described as a burning pain in the arch or
distal foot that occurs while the patient is recumbent but is
relieved when the patient returns to a position in which the
feet are dependent. Major amputation is eventually needed in
more than one third of these patients once the threatening
symptoms and signs occur.   Mortality is closely related to
critical limb ischaemia, with a one-year mortality rate of
about 20% in several series17. 
Complications of Pad
PAD may lead to nonhealing wounds, gangrene and
amputations.  Nonhealing wounds are usually found in areas
of foot trauma caused by improper fitting shoes or an injury17.
Gangrene is usually found on the toes and it develops when
the blood supply is so low that spontaneous necrosis occurs
in the most poorly perfused tissues17.  Amputation is indicated
in cases where extensive tissue necrosis or life-threatening
infection occurs and in cases where the lesions are not
amenable to surgery17.  Diabetic patients with lower
extremities PAD are at increased risk of developing these
complications such as foot ulcer, ischaemia, gangrene and
amputation10.  The development of foot ulcers in persons with
diabetes mellitus (DM) is due to a combination of PAD and
peripheral neuropathy8.  The risk of lower extremity
amputation has been estimated to be 15 times greater in
diabetics than non-diabetics10.  In patients who have already
had a leg amputation, 30% of them require an amputation of
the remaining limb within three years8.  The mortality rate in
diabetic patients after lower extremity amputation has been
estimated to be about 5-7 times higher than the general
population8. 
A retrospective study carried out in General Hospital Kuala
Lumpur in 1972-79 on 132 patients revealed that diabetes
mellitus was the cause in 43% of all lower limb amputation.
Moreover, patients with diabetes mellitus and PAD have a
higher failure rate for below knee amputations carried out for
gangrene of the extremities18.  Hence the American Diabetic
Association recommends comprehensive foot screening for
all patients with DM, which includes vascular, neurological,
musculoskeletal, skin and soft tissue evaluations, and these
should be performed annually8.
Diagnosis of Pad
The diagnosis of PAD can be made on the basis of physical
examination, symptoms of IC by the use of Rose
Questionnaires or Edinburgh Claudication Questionnaires16
and by measuring ABPI. 
Physical Examination
Physical examination of patients with PAD may reveal absent
or decreased peripheral pulses19.  However the dorsalis pedis
artery is congenitally absent in 2% of population and post
tibialis artery in 0.1%20.  Physical signs that further support
the diagnosis of PAD include decreased skin temperature,
shiny, hairless skin over the lower extremities, dystrophic
toenails, pallor on elevation of the extremity and rubor when
the limb is dependent19.
Intermittent Claudication Questionnaires
The clinical diagnosis of PAD may be made on the basis of an
accurate history by using the WHO/ROSE IC questionnaires
or the Edinburgh Claudication Questionnaires, an improved
version of the WHO questioonaire21.  The ECQ was found to
be 91.3% sensitive and 99.3% specific in detecting IC among
general population compared to the clinical diagnosis of
PAD21.
Ankle Brachial Pressure Index 
PAD is common but often goes undiagnosed because nearly
90% of patients do not report classical symptoms of IC22.
Using classic symptomatic IC as a marker tends to
substantially underestimate the prevalence of PAD22.  In fact if
non-invasive tests such as APBI are used to identify such
problems in both symptomatic and asymptomatic patients,
significant PAD appears to be 2-7 times more common than
the prevalence of IC would suggest23.  Hence screening at risk
patients using the ABPI can increase the detection rate of
PAD23.
The ABPI is measured by placing the patient in a supine
position for 5 minutes. Brachial systolic blood pressure (BP) is
measured in both arms and is used as the denominator of the
ABPI.  Ankle systolic BP is measured in a resting position with
a 12-cm wide occluding cuff placed just above the ankle with
a Doppler device used as a distal sensor25.  Ankle systolic BP is
then measured in the dorsalis pedis and the post tibial
arteries.  The higher value of the dorsalis pedis and the post
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tibial arteries is taken as the numerator of the ABPI in each
limb.  ABPI is then calculated by dividing the ankle systolic
BP by the brachial systolic BP in each limb24.
Ankle Brachial Pressure Index is an effective way to detect
PAD.  An ABPI of less than 0.90 is considered diagnostic of
PAD.  Mild disease correlates with an ABPI of 0.70 to less than
0.90, moderate disease correlates with an ABPI of 0.40-0.70,
and severe disease correlates with an ABPI of less than 0.409.
The sensitivity of ABPI is 90% and the specificity is 98% for
an angiographically defined stenosis of 50% or more in a
major leg artery4.  ABPI is a significant predictive variable for
disease severity9.  Hence the American Heart Association has
recommended screening high-risk patients in clinical setting
for PAD with the ABPI24.
However an ABPI value of more than 1.3 suggests poorly
compressible arteries at the ankle level, which is especially
common among the diabetics due to the presence of medial
arterial calcification. This renders the diagnosis of ABPI less
reliable in these patients and toe pressure index has been used
as an alternative diagnostic tool9. 
Other modalities of investigations such as colour duplex
imaging, duplex ultrasound, magnetic resonance imaging
and magnetic resonance angiography are reserved for a
minority of patients in whom invasive intervention are
considered25.
Treatment
The most important step in treating patients with PAD is
lifestyle modifications and exercise.  This follows by
addressing patient’s risk factors.
Exercise
All patients with PAD should be advised to exercise regularly.
Exercise has been shown to improve peak walking distance
and pain free walking distance by 100% or greater25.
RISK FACTOR MODIFICATIONS
Smoking Cessation       
Complete and permanent cessation of smoking is by far the
single most important factor determining the outcome of
patients with IC17.  Unfortunately the rates of smoking
cessation after simple oral or written advice from a doctor are
as low as 13% at two years25.  However RCTs have shown that
nicotine replacement treatment and bupripion
approximately doubles the cessation rate25.
Hyperglycemia 
Although good glycaemic control has been established to
slow progression of microvascular disease, there is conflicting
evidence about whether it affects the severity or progression
of PAD11.  Nonetheless the combination of DM and PAD
results in a worse prognosis with regards to local progression
and eventual amputation11.  Therefore aggressive glycaemic
control remains important in diabetic patients with PAD11.
Hypertension
Hypertension has been shown to be linked with PAD4, 5,26.  The
Heart Outcome Prevention (HOPE) trial has shown that
ramipril, an angiotensin converting enzyme inhibitor,
reduces cardiovascular morbidity and mortality in patients
with PAD by 25%26.  The ABCD (Appropriate blood Pressure
control in Diabetes) trial showed that patients with PAD and
DM, intensive blood pressure lowering to a mean of 128/75
mmHg had resulted in a marked reduction in cardiovascular
events27.
Hyperlipedemia
Hyperlipidemia is a common feature in PAD and is an
important risk factor for macrovascular disease11. The heart
protection study had shown that lowering total cholesterol
and low-density cholesterol by 25% with a statins reduced
cardiovascular mortality and morbidity in patients with PAD
by around a quarter irrespective of age, sex or baseline
cholesterol concentration16.  Furthermore reducing serum
cholesterol levels has been associated with improved
endothelial function in patients with PAD26.
MEDICAL MANAGEMENT
Antiplatelet Agents
The Antiplatelet Trialists Collaboration showed that aspirin
reduces vascular death in patients with atherosclerotic disease
by about 25% and that antiplatelet agents were equally
effective in patients who present with CAD and PAD.
Clopidogrel is at least as effective as and possibly more
effective than aspirin in patients with PAD and has a better
side effect profile25.
Referral 
Patient with critical limb ischaemia (rest pain, gangrene or
ulceration) should be referred urgently to vascular surgeons.
Other circumstances when referral to vascular surgeon is
appropriate include: a second opinion is needed on diagnosis,
the resources needed to institute and monitor medical
treatment are lacking, there is concern that the symptoms
may have an unusual cause, the patient has unacceptable
symptoms despite a reasonable trial of and adherence to
medical treatment, or the patient has weak or absent pulses25.
Surgical Management
Surgical intervention has been reserved for rest pain, tissue
loss and patient defined disabling claudication. Improvement
in blood supply to the lower limbs involves vascular surgical
treatment by endarterectomy and or bypass surgery28.
However outcomes from these interventions in patients with
DM tend to be poorer than the nondiabetic patients and
revascularization is technically more difficult in diabetic
patients11.
Radiological Intervention
Recently there has been a dramatic increase in the use of
interventional radiological procedures for the treatment of
acute and chronic lower extremity arterial disease. The
primary indications for an interventional procedure in
patients with lower extremity arterial disease include
incapacitating claudication interfering with work or lifestyle,
limb salvage in patients with limb-threatening ischemia as
manifested by pain at rest, nonhealing ulcers, and/or
infection or gangrene; and vasculogenic impotence29. These
interventional treatments include percutaneous transluminal
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angioplasty (PTA), which accounts for approximately 30% of
re-vascularization procedures, intravascular stents, and the
more widespread use of intra-arterial thrombolysis for the
treatment of peripheral arterial thrombosis29.
CONCLUSION
More emphasis should be placed on preventive care, early
detection and health promotion of such a common disease in
an effort to improve quality of life and curb the rising health
care costs associated with peripheral arterial disease. 
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MCQ‘S: 
1. Peripheral arterial disease may present as 
A. Pain in calf muscles
B. Headache
C. Rest pain
D. Impotence
E. Weakness
2. Important risk factors for PAD are
A. Hypertension
B. Diabetes mellitus
C. Physical activity
D. Smoking
E. Male gender
3. In patients with diabetes PAD is
A. More common
B. Progress slowly
C. Localized 
D. Associated with microangiopathy
E. Less symptomatic
4. Complications of PAD are
A. Ulceration
B. Numbness
C. Gangrene
D. Amputation
E. Ischaemia
5. The diagnosis of PAD can be made on the basis of
A. Absence of peripheral pulses
B. Symptoms of intermittent claudiaction
C. Ankle brachial pressure index >0.90
D. Colour duplex imaging
E. CT scan
